skip to main content

S. 2917 (113th): Adding Ebola to the FDA Priority Review Voucher Program Act

The text of the bill below is as of Jan 1, 2014 (Passed Congress).


One Hundred Thirteenth Congress of the United States of America

2d Session

S. 2917

IN THE SENATE OF THE UNITED STATES

AN ACT

To expand the program of priority review to encourage treatments for tropical diseases.

1.

Short title

This Act may be cited as the Adding Ebola to the FDA Priority Review Voucher Program Act .

2.

Priority review to encourage treatments for tropical diseases

Section 524 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360n ) is amended—

(1)

in subsection (a)(3)—

(A)

by redesignating subparagraph (Q) as subparagraph (R);

(B)

by inserting after subparagraph (P) the following:

(Q)

Filoviruses.

; and

(C)

in subparagraph (R), as so redesignated, by striking regulation by and inserting order of; and

(2)

in subsection (b)—

(A)

in paragraph (2), by adding There is no limit on the number of times a priority review voucher may be transferred before such voucher is used. after the period at the end; and

(B)

in paragraph (4), by striking 365 days and inserting 90 days.

Speaker of the House of Representatives

Vice President of the United States and President of the Senate